Fig. 1 · Structure

Documents & Downloads

Lobetyolin

Cat. No. A12225 CAS 136085-37-5
Lobetyolin is isolated from the hairy roots of Lobelia inflata.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Lobetyolin Research Summary

This section summarizes 2 in vitro studies and 2 in vivo studies of Lobetyolin from 3 published references. In vitro models include NCI-H292 cells. In vivo models include male C57BL/6 mice.

Lobetyolin In Vitro Studies

In NCI-H292 cells treated before PMA stimulation, Lobetyolin did not affect PMA-induced MUC5AC mucin production compared with PMA alone. Lobetyolin also did not affect PMA-induced MUC5AC mucin secretion in this comparison. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Lobetyolin and PMA-induced mucin production

Cell-based study · NCI-H292 cells [1]

NCI-H292 cells were treated with Lobetyolin in culture medium before PMA stimulation. Lobetyolin did not affect PMA-induced MUC5AC mucin production compared with PMA alone.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Cell lysates were collected for measuring MUC5AC mucin production by enzyme-linked immunosorbent assay.MUC5AC production 524±38%, 411±24%, and 402±45%[1]

Literature-Reported Treatment Conditions

Treatment concentration
1, 10, and 100 µM
Exposure duration
for 30 minutes and then stimulated with PMA (10 ng/mL) for 24 hours
Method
treated in culture medium
Vehicle
dissolved in dimethylsulfoxide, diluted in PBS
Co-treatment
Other interventions in this design: phorbol 12-myristate 13-acetate 10 ng/mL. Compound effect isolated by the comparison: 10 ng/mL of PMA alone.
Methods and source locations

Compound reported in the paper: Lobetyolin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > 3. Treatment of cells with lobetyolin, lobetyol and methyl linoleate (S14, S15); Results > 2. Effect of lobetyolin, lobetyol or methyl linoleate on PMA-induced MUC5AC production from NCI-H292 cells (S40, S42); Figure 2 legend (S56, S57)

Cell lysates were collected for measuring MUC5AC mucin production by enzyme-linked immunosorbent assay.: Cell lysates were collected for measuring MUC5AC mucin production by enzyme-linked immunosorbent assay.; comparator: 10 ng/mL of PMA alone — Results > 2. Effect of lobetyolin, lobetyol or methyl linoleate on PMA-induced MUC5AC production from NCI-H292 cells (S40, S42); Figure 2 legend (S57)

Lobetyolin and PMA-induced mucin secretion

Cell-based study · NCI-H292 cells [1]

NCI-H292 cells were treated with Lobetyolin in culture medium before PMA stimulation. Lobetyolin did not affect PMA-induced MUC5AC mucin secretion compared with PMA alone.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Spent media were collected for measuring MUC5AC mucin secretion by enzyme-linked immunosorbent assay.MUC5AC secretion 294±26%, 302±17%, and 289±35%[1]

Literature-Reported Treatment Conditions

Treatment concentration
1, 10, and 100 µM
Exposure duration
for 30 minutes and then stimulated with PMA (10 ng/mL) for 24 hours
Method
treated in culture medium
Vehicle
dissolved in dimethylsulfoxide, diluted in PBS
Co-treatment
Other interventions in this design: phorbol 12-myristate 13-acetate 10 ng/mL. Compound effect isolated by the comparison: 10 ng/mL of PMA alone.
Methods and source locations

Compound reported in the paper: Lobetyolin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and Methods > 3. Treatment of cells with lobetyolin, lobetyol and methyl linoleate (S14, S15); Results > 3. Effect of lobetyolin, lobetyol or methyl linoleate on PMA-induced MUC5AC secretion from NCI-H292 cells (S46, S47); Figure 3 legend (S61, S62, S63)

Spent media were collected for measuring MUC5AC mucin secretion by enzyme-linked immunosorbent assay.: Spent media were collected for measuring MUC5AC mucin secretion by enzyme-linked immunosorbent assay.; comparator: 10 ng/mL of PMA alone — Results > 3. Effect of lobetyolin, lobetyol or methyl linoleate on PMA-induced MUC5AC secretion from NCI-H292 cells (S46, S47); Figure 3 legend (S63)

Lobetyolin In Vivo Studies

Intraperitoneal Lobetyolin inhibited tumour volume in athymic nude mice inoculated subcutaneously with HCT116 cells compared with vehicle controls. In male C57BL/6 mice with IMQ-induced psoriasis, topical Lobetyolin at 10 mM or PBS was applied for 5 days. Skin tissue metabolomics identified 119 downregulated and 101 upregulated metabolites in this comparison. [2,3]

Lobetyolin and tumour volume in mice

Animal study · 6‐week‐old athymic nude (nu/nu) mice (SPF grade); subcutaneously inoculated with HCT116 cells (2 × 106 cells) at the right flank; n = 10 [2]

Athymic nude mice inoculated subcutaneously with HCT116 cells received intraperitoneal Lobetyolin at 10 mg/kg, 20 mg/kg and 40 mg/kg. Treatment inhibited tumour volume compared with the vehicle control group.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
tumour volumeReported result The Lobetyolin (10, 20, 40 mg/kg) treatment obviously inhibited the tumour volume compared with that in control group.[2]

Conditions shared by the study groups

Route
intraperitoneally injected
Treatment course
24 hours after tumour transplantation; for 2 weeks
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Lobetyolin Lobetyolin (10 mg/kg), Lobetyolin (20 mg/kg) and Lobetyolin (40 mg/kg)the control group intraperitoneally received vehicle for 2 weeksThe Lobetyolin (10, 20, 40 mg/kg) treatment obviously inhibited the tumour volume compared with that in control group.[2]
Lobetyolin Lobetyolin (10 mg/kg), Lobetyolin (20 mg/kg) and Lobetyolin (40 mg/kg)
Model: 6‐week‐old athymic nude (nu/nu) mice (SPF grade); subcutaneously inoculated with HCT116 cells (2 × 106 cells) at the right flank; n = 10
Reported limits: Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Lobetyolin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

MATERIALS AND METHODS > Animals (S30, S32, S33, S34); RESULTS > The effect of Lobetyolin on tumour growth in vivo (S121)

tumour volume: tumour volume; comparator: the control group intraperitoneally received vehicle for 2 weeks — RESULTS > The effect of Lobetyolin on tumour growth in vivo (S121)

Lobetyolin Lobetyolin (10 mg/kg), Lobetyolin (20 mg/kg) and Lobetyolin (40 mg/kg) · MATERIALS AND METHODS > Animals (S33, S34); RESULTS > The effect of Lobetyolin on tumour growth in vivo (S121)

Lobetyolin and skin metabolite profiles in psoriasis mice

Animal study · male C57BL/6 mice [3]

Male C57BL/6 mice with IMQ-induced psoriasis received topical Lobetyolin at 10 mM or PBS for 5 days. Non-target metabolomics of skin tissues identified 119 downregulated and 101 upregulated metabolites in this comparison.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
non-target metabolomics in skin tissuesReported result IMQ-induced psoriasis mice treated with 10 mM LBT or PBS for 5 days: A total of 119 downregulated and 101 upregulated metabolites were identified.[3]

Conditions shared by the study groups

Route
applied topically
Treatment course
applied topically twice daily; for 5 days
Vehicle
PBS
Study groups and reported outcomes
Group / doseComparatorObserved resultReference
Lobetyolin 10 mMPBSIMQ-induced psoriasis mice treated with 10 mM LBT or PBS for 5 days: A total of 119 downregulated and 101 upregulated metabolites were identified.[3]
Lobetyolin 10 mM
Model: male C57BL/6 mice
Reported limits: Removed after verification: value.
Methods and source locations

Compound reported in the paper: Lobetyolin

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

Materials and methods > IMQ induced psoriasis-like skin inflammation in the mice model (S16, S17); Results > LBT could promote expression of the genes and metabolites related to linoleic metabolism in skin tissue of psoriasis mice (S124); Figure 4 legend (S174, S179)

non-target metabolomics in skin tissues: non-target metabolomics in skin tissues; comparator: PBS — Results > LBT could promote expression of the genes and metabolites related to linoleic metabolism in skin tissue of psoriasis mice (S124); Figure 4 legend (S174)

Lobetyolin 10 mM · Materials and methods > IMQ induced psoriasis-like skin inflammation in the mice model (S17); Results > LBT could promote expression of the genes and metabolites related to linoleic metabolism in skin tissue of psoriasis mice (S124); Figure 4 legend (S174)

Specifications

Manufacturer Adooq Bioscience
CAS Number 136085-37-5
Alternate CAS 129277-38-9
Formula C20H28O8
Molecular Weight 396.43
SMILES
C/C=C/C#CC#CC(C(/C=C/CCCO)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Lobetyolin Research References

  1. [1] Yoon YP, Ryu J, Park SH, et al. Effects of Lobetyolin, Lobetyol and Methyl linoleate on Secretion, Production and Gene Expression of MUC5AC Mucin from Airway Epithelial Cells. Tuberc Respir Dis (Seoul) (2014). PMID: 25473407 DOI: 10.4046/trd.2014.77.5.203 Source material
  2. [2] He W, Tao W, Zhang F, et al. Lobetyolin induces apoptosis of colon cancer cells by inhibiting glutamine metabolism. J Cell Mol Med (2020). PMID: 31990147 DOI: 10.1111/jcmm.15009 Source material
  3. [3] He J, Feng C, Xu Y, et al. Lobetyolin alleviates IMQ‑induced psoriasis‑like skin inflammation by maintaining the homeostasis of the skin and inhibiting the inflammatory cytokines in dendritic cells. Int J Mol Med (2025). PMID: 40511547 DOI: 10.3892/ijmm.2025.5563 Source material

Added to your cart

View Cart Checkout
Loading...